Clinical pharmacists participated in the consultation on thrombocytopenia for a patient with pulmonary infection,and determined the possible causes.After the analysis,clinical pharmacists found that thrombocytopenia in the patient might be closely related to infection,especially COVID-19 infection.An anti-infection drug cefoperazone sodium and sulbactam sodium was a possible factor for thrombocytopenia.What's more,clopidogrel tablets might not be excluded.Clinical pharmacists suggested the patient should be treated with platelet-raising drugs.Clopidogrel may continue under close monitoring,while cefoperazone sodium and sulbactam sodium should be stopped.The platelets levels returned to normal finally.Medical workers should try to determine the various causes of thrombocytopenia.When drug adverse reactions were doubted,clinical pharmacists need to cooperate with physicians in deciding on treatment plan.
关键词
肺部感染/血小板减少/新型冠状病毒感染/药物不良反应
Key words
pulmonary infection/thrombocytopenia/COVID-19/adverse drug reaction
维普
万方数据